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ANALYSIS
People are offered a wide range of screen-
ing tests by diverse providers. For example: 
maternal and child health services screen 
for genetic conditions and developmen-
tal problems; general practitioners screen 
for cardiovascular risk factors; NHS pro-
grammes screen for bowel, breast, and cer-
vical cancer; and commercial providers offer 
various health assessments, including body 
and gene scans. Provision of tests is not well 
regulated, and there is a bewildering amount 
of information of variable accuracy in the 
public domain.1
It is unclear how healthcare providers 
should communicate about screening in 
order to support appropriate uptake. And 
what constitutes appropriate uptake is also 
contested because of disagreements about 
the merits of particular tests and tensions 
between concerns to promote health and to 
respect autonomy.2-4 Debates about commu-
nication have tended to consider two types 
of approach, which we call “be screened” 
and “analyse and choose.” We consider their 
problems and propose a third approach, 
“consider an offer.”
Be screened
The be screened approach aims to persuade 
people to have screening, usually with a view 
to promoting health gain, cost effective serv-
ice provision, or profit.2-4 Its key features are 
encouragement to be screened; an emphasis 
on the benefits of screening and de-emphasis of 
potential harms; and a lack of recognition that 
it might be reasonable not to be screened.
This approach is found in commercial 
advertisements and some invitations to par-
ticipate in government funded screening 
programmes. For example, the leaflet Breast 
Cancer: the Facts, from the NHS Breast Cancer 
Screening Programme presents screening as 
necessary for women aged over 50.5 It asks, 
“Should all women have breast screening?” 
and gives no hint of any scope for a nega-
tive answer. The leaflet highlights the benefits 
of mammography and describes the main 
processes but plays down potential harms. It 
does not mention that screening may lead to 
overtreatment or that clinicians and epidemi-
ologists seriously dispute the value of breast 
screening. It gives no indication that women 
might reasonably choose not to be screened, 
and includes a breast awareness code that 
instructs women to “Go for breast screening 
every 3 years if you are over 50.”
The main criticisms of the be screened 
approach are that it inadequately reflects the 
benefit-harm profile of screening tests and 
fails to respect autonomy because it does 
not facilitate informed decision making by 
individuals.6-8 Some communications with 
features typical of this approach purport to 
facilitate informed choice, but they present 
only one option: to be screened.
Analyse and choose
The analyse and choose approach is one 
response to criticisms of the be screened 
approach. It emphasises respect for auton-
omy and treats this as a matter of ensuring 
that competent individuals have sufficient 
understanding of their options and can 
make intentional, sufficiently independent 
choices.9 It assumes that sufficient under-
standing requires comprehension of detailed 
research based information about benefits 
and harms and promotes informed individ-
ual decision making based on this.
The key features of this approach are an 
emphasis on the importance of individual 
(sometimes independent) choice and the 
provision of comparative data about the 
various outcomes of screening and no 
screening. The approach is exemplified by 
decision aids, which seek to present the data 
in accessible ways. 
There are three main criticisms of the ana-
lyse and choose approach. Firstly, the impli-
cation that everyone eligible for screening 
should consider detailed effectiveness data 
may be unnecessarily burdensome. This 
criticism is particularly strong when expert 
committees acting in the public interest have 
reviewed the available research, judged the 
tests to be broadly effective and acceptable, 
and supported the introduction of government 
endorsed screening programmes. Secondly, 
there are concerns that encouraging detailed 
decision analysis by individuals might not 
lead to good choices (it might disrupt peo-
ple’s usual effective decision making proc-
esses) or deter uptake of effective, appropriate 
screening.4 7 10 11  Thirdly, some critics think 
this approach overemphasises rational and 
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independent decision making—reflecting an 
inappropriately narrow understanding of 
autonomy.
New considerations
Recent research into decision making has 
highlighted some potential downsides of 
detailed decision analysis and maximising 
(aiming to make the best possible choice). It 
suggests that heuristics and “satisficing” (aim-
ing to make good enough choices) can be 
less burdensome and yield better decisions 
and outcomes.12 13
The understanding of autonomy that pre-
vails in health care has been criticised for 
focusing too narrowly on discrete decisions, 
over-idealising rationalism, and inappropri-
ately assuming that interpersonal collabora-
tion and trust will compromise rather than 
promote autonomy.14-16 Although autonomy 
relates to individuals, it is both developed 
and exercised in the context of social rela-
tionships.16-18 People who use “intellectual 
outsourcing” to help shape their opinions, 
and who do not  process detailed data for 
themselves before they choose or act, do 
not necessarily fail to exercise autonomy,18 
although others who try to impose their 
views and discourage competent considera-
tion of alternatives do tend to undermine it.
Neither of the two approaches above con-
siders the importance of the interests and 
trustworthiness of those who offer and advise 
about screening. This failing, together with 
recent evidence about what patients value 
about communication with health profes-
sionals19 and involvement in decision mak-
ing,20 leads us to suggest a third approach to 
communication about screening.
Consider an offer
The consider an offer approach is designed to 
respect personal autonomy without overbur-
dening people with unwanted information and 
decision making tasks and without deterring 
uptake of effective and personally appropriate 
screening. Within this approach, communica-
tors either recommend or offer screening or 
help people to consider recommendations or 
offers from others. They openly explain and 
discuss the basis for the recommendation or 
offer; encourage and facilitate an individual 
assessment of the recommendation or offer 
(including consideration of the potential bias 
and trustworthiness of those making it and of 
its personal relevance); provide or facilitate 
access to further information if that is required; 
and acknowledge that the recommendation or 
offer might reasonably be refused.
Just what information and how much detail 
are required will vary across screening tests, 
contexts, and individuals, but will usually 
include a summary of the potential benefits 
and harms of the test considered, considera-
tion of any known objections to it, informa-
tion about test providers, and factors that 
might affect the appropriateness of the test 
for particular individuals (table). The optional 
extra information might include detailed data 
on outcomes and, more controversially, other 
people’s experiences and preferences, espe-
cially in value laden contexts such as screen-
ing for fetal abnormality.7  
When presented with a screening offer, 
people might reasonably respond in various 
ways. Some might judge the trustworthiness 
and personal relevance of a screening offer on 
the basis of the initial communication; others 
might habitually seek and follow the advice 
of a trusted health professional; and others 
might want to evaluate research evidence for 
Illustration of communication by general practitioner consistent with consider an offer approach to screening 
Key communication topics Rationale Response to a healthy 45 year old’s query 
about prostate cancer screening
Recommendation of cardiovascular risk 
assessment 
Who made the recommendation or offer? Being able to depend on others appropriately 
is essential for autonomy.16 Information 
about the individuals, committees, and 
organisations that recommend or offer screening 
can help people assess their trustworthiness 
and identify potential concerns about their 
recommendations or offers 
Although several men’s groups are 
campaigning for screening, the National 
Screening Committee, which is required to 
review the evidence very carefully, does not 
think that routine screening for prostate cancer 
is justified
The National Institute for Health and Clinical 
Excellence and all the major professional 
and patient groups have worked together 
and now recommend that we carry out a 
cardiovascular risk assessment for most 
people aged 45 and over
What is the basis of the recommendation, 
and what are the main benefits and harms of 
screening?
An explanation of how a recommendation 
was reached may help people to assess 
its trustworthiness. Information about 
consequences is an important component of 
practical reasoning, and people usually want to 
know (or at least not be misled about) the main 
reasons for or against healthcare interventions
Although prostate cancer kills many men, a lot 
of men have prostate cancer but do not die from 
it . . . Prostate specific antigen (PSA) testing 
will pick up some prostate cancers but will 
also miss some. And we can’t tell which of the 
prostate cancers that it does pick up would be 
life threatening. When a man is found to have 
prostate cancer after being screened, no one can 
be sure if current treatments will leave him better 
off than if he had not been screened. Research is 
ongoing, but at the moment we really don’t know 
the overall effects of PSA testing
Studies following thousands of people over 
several decades have allowed experts to 
develop accurate estimates of how likely 
individuals are to have a heart attack or 
stroke, based on their age, sex, family 
history, blood pressure, blood cholesterol, 
and whether they smoke. Many things can 
be done to reduce the risk and screening 
would allow us to discuss options 
appropriate for your level of risk
Are there any factors that make the screening 
test more appropriate for some people than 
others?
Beyond a clear statement about who a 
recommendation or offer applies to, it may be 
useful to highlight circumstances that can make 
screening more or less appropriate for particular 
individuals—eg, age and risk exposures that 
modify the likelihood of benefit and values that 
can give people reason to accept or decline 
screening tests
Prostate cancer is rare in men under 50 and 
you have no family history of prostate cancer, 
so the chances of you having it are relatively 
low. But if you are particularly anxious about it 
and concerned to find out, then we should take 
that into account—but still bearing in mind that 
the test is not 100% accurate and may lead to 
unnecessary treatment
You’re a heavy smoker, which increases 
your risk of heart disease and stroke. If 
you’re worried about having a stroke like 
your uncle, screening might help us think 
again about the smoking and look at other 
ways you can reduce that risk
Who might gain from screening and how are 
people protected?
Information about the financial and other 
significant interests of the organisations and 
individuals that recommend, offer, and provide 
screening are relevant in some contexts 
Although I wouldn’t really recommend it, I can 
arrange for a PSA test for you on the NHS… 
You’ll find private health care providers more 
enthusiastic about the test—but then they can 
make money from it in a way that I can’t
The income we get from government to 
help run the practice depends in part on 
us doing some of these checks, but we 
recommend it because we think it can help 
patients. The practice would still care for 
you if you chose not to be screened
Is more information needed? People’s information needs vary. Initial 
communications can usefully encourage 
people to consider whether they have enough 
information and enable those who want more to 
access other potentially useful sources
Has that given you enough information, or 
would you like more detail or more time to think 
about it? I have a leaflet here that summarises 
the information we’ve talked about, and it lists 
a few other sources of information
Does that give you enough to go on? I 
can give you more information, or point 
you towards a website that explains the 
assessment in more detail
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themselves—at least for some tests. It should be 
feasible to respond to these varied preferences 
even when communications are necessarily 
standardised to some extent. For example, 
mailed invitations from national screening pro-
grammes can encourage people to consider 
whether they would like more information and 
tell them where to find additional resources 
and personal support.
This approach respects autonomy because 
it encourages and enables people to consider 
screening offers carefully. Although it can 
incorporate strong recommendations, it does 
not close down opportunities for thoughtful 
refusals of screening. For example, practition-
ers will avoid presenting screening as routine16 
or necessary and will ensure people feel they 
can safely say they do not think a test is right 
for them. The consider an offer approach can 
facilitate informed decision making about 
screening, providing summary information 
about the benefits and harms of screening to all 
and decision aids with more detailed epidemi-
ological information to those who want them 
(figure), but it does not assume that autono-
mous choice or informed decision making 
will always require every individual to work 
through detailed statistics for themselves. 
Because it accepts the reality of intellectual 
outsourcing18 and the importance of trust, 
the consider an offer approach makes people 
vulnerable to manipulation: trust can be both 
inappropriately placed and abused.21 How-
ever, this vulnerability is arguably no greater 
than with the be screened approach. Consider 
an offer provides some protection by discuss-
ing the basis of recommendations or offers, 
facilitating assessment of the trustworthiness of 
those who make them, and raising questions 
about the adequacy of the information sup-
plied. The further protection that the analyse 
and choose approach offers by encouraging 
rational personal decisions based on detailed 
data on outcomes is not practical for many.
For screening programmes backed by agen-
cies such as the National Screening Commit-
tee, the consider an offer approach should not 
adversely affect uptake of broadly effective 
tests. Communication consistent with this 
approach should help people to recognise 
when providers are trustworthy. In contrast, 
the be screened approach might lead to mis-
trust over time if people come to realise prac-
titioners have underplayed the downsides of 
screening.
The consider an offer approach is less 
demanding on those eligible for screening 
than the analyse and choose approach, but it 
puts more onus on providers to communicate 
in a range of ways to meet diverse informa-
tion needs. Some programmes already use 
features of consider an offer—for example, 
information about newborn bloodspot tests 
presents recommendations and explanations 
and points out that tests are not compulsory.22 
But if the approach is found to be successful, 
health service agencies will need to develop 
more resources to support adoption by front 
line health professionals.
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